The frequent hyper-methylation and under-expression of CXCL5 were validated in five of the cell lines and five osteosarcoma tumour samples using methylation-specific PCR and quantitative real-time RT-PCR, respectively (Figure 8 and S7). This evidence concerns the gene CXCL5 and neoplasm.